MoleculeMind is dedicated to advancing innovation in protein design and optimization through AI. At its core is MoleculeOS, a cutting-edge AI-powered platform for biologics optimization and design. By harnessing data-driven deep learning, this platform empowers professionals across R&D fields to identify and generate biologic candidates with unparalleled efficiency. Its applications span a broad spectrum: from the research and design of therapeutic peptides, antibodies, enzymes, vaccines and small proteins to protein optimization in chemistry, materials science, synthetic biology, industry, and agriculture. Backed by a suite of independently developed AI algorithms for protein prediction, optimization, and design tools, MoleculeMind is transforming the landscape of protein-related R&D, driving innovation and commercial progress across associated industries.
| Website | http://www.moleculemind.com/ |
| Employees | 29 (18 on RocketReach) |
| Founded | 2022 |
| Industry | Biotechnology Research |
| Keywords | Ai Drug Discovery, Drug Development, Protein Design, Protein Engineering, Molecular Modeling, Biotechnology, Computational Biology, Molecular Simulation, Generative Ai, Pharmaceutical, Bioinformatics, Machine Learning, Ai Platform, Precision Medicine, Synthetic Biology, Deep Learning, Data Driven, Materials Science, Agricultural Technology |
| Competitors | Tempus Labs, Inc., Foundation Medicine, Guardant Health, 23andMe Inc, GRAIL, Caris Life Sciences, Invitae, Myriad Genetics, Freenome, Natera +47 more (view full list) |
Looking for a particular MoleculeMind employee's phone or email?
Hongzhong Wu is the Vice President of Business Development and Financing of MoleculeMind.
18 people are employed at MoleculeMind.